ElIAPixant 是一种选择性的P2X3受体拮抗剂，IC50值为 8 nM，可用于难治性慢性咳嗽的研究。

Eliapixant (BAY 1817080) is a potent and selective P2X3 receptor antagonist, with an IC50 of 8 nM. Eliapixant can be used for the research of refractory chronic cough.

Eliapixant can be used in the study of coughs and diabetes complications[1].

1948229-21-7

C22H21F3N4O3S

478.49

BAY 1817080

DMSO:30mg/mL (62.70mM),ultrasonic and warming and heat to 60℃
Powder: -20°C for 3 years
In solvent: -80°C for 2 years